Literature DB >> 12835364

Feasibility of prehospital treatment with activated charcoal: Who could we treat, who should we treat?

G K Isbister1, A H Dawson, I M Whyte.   

Abstract

OBJECTIVES: To investigate the feasibility and potential risk benefit of prehospital administration of activated charcoal.
METHODS: Review of deliberate self poisoning presentations to the emergency department (ED) of a toxicology unit by ambulance over six years. Data were extracted from a standardised prospective database of poisonings. Outcomes included: number of patients attended by ambulance and number arriving in emergency within one hour. Cases were stratified by ingestion type, based on toxicity and sedative activity.
RESULTS: 2041 poisoning admissions were included. The median time to ambulance attendance was 1 h 23 min (IQR 37 min-3 h) and to hospital attendance was 2 h 15 min (IQR 1 h 25 min-4 h). In 774 cases (38%) ambulance attendance occurred within one hour, but in only 161 (8%) did ED attendance occur within one hour. Non-sedating, highly toxic substances were ingested in 55 cases, 24 (23 with GCS>14) with ambulance attendance, and five with ED attendance, within one hour. Conversely 439 patients ingested a less toxic, sedative agent, 160 with ambulance attendance, and 32 with ED attendance, within one hour. Limiting decontamination to patients ingesting highly toxic, non-sedating compounds (GCS<14) reduces the proportion requiring treatment to 23 of the 774 (3.0%), an additional 18 patients.
CONCLUSION: More patients could potentially be decontaminated if all patients attended by ambulance within one hour received charcoal. However, this would expose 128 patients with sedative, low risk poisonings to the risk of aspiration, and only treat 18 extra high risk poisonings. This small potential benefit of prehospital charcoal is unlikely to justify the expense in training and protocols required to implement it

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12835364      PMCID: PMC1726162          DOI: 10.1136/emj.20.4.375

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  17 in total

Review 1.  Position statement: single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists.

Authors:  P A Chyka; D Seger
Journal:  J Toxicol Clin Toxicol       Date:  1997

2.  Fatal pulmonary aspiration of oral activated charcoal.

Authors:  D G Menzies; A Busuttil; L F Prescott
Journal:  BMJ       Date:  1988-08-13

3.  How feasible is it to conform to the European guidelines on administration of activated charcoal within one hour of an overdose?

Authors:  A Karim; S Ivatts; P Dargan; A Jones
Journal:  Emerg Med J       Date:  2001-09       Impact factor: 2.740

4.  Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose.

Authors:  N A Buckley; I M Whyte; D L O'Connell; A H Dawson
Journal:  J Toxicol Clin Toxicol       Date:  1999

5.  Preformatted admission charts for poisoning admissions facilitate clinical assessment and research.

Authors:  N A Buckley; I M Whyte; A H Dawson; D A Reith
Journal:  Ann Emerg Med       Date:  1999-10       Impact factor: 5.721

6.  Evaluation of administration of activated charcoal in the home.

Authors:  H A Spiller; G C Rodgers
Journal:  Pediatrics       Date:  2001-12       Impact factor: 7.124

7.  Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions.

Authors:  T E Albertson; R W Derlet; G E Foulke; M C Minguillon; S R Tharratt
Journal:  Ann Emerg Med       Date:  1989-01       Impact factor: 5.721

8.  Self-poisoning in Newcastle, 1987-1992.

Authors:  N A Buckley; I M Whyte; A H Dawson; P R McManus; N W Ferguson
Journal:  Med J Aust       Date:  1995-02-20       Impact factor: 7.738

9.  Gastric emptying in acute overdose: a prospective randomised controlled trial.

Authors:  S M Pond; D J Lewis-Driver; G M Williams; A C Green; N W Stevenson
Journal:  Med J Aust       Date:  1995-10-02       Impact factor: 7.738

10.  Relative toxicity of benzodiazepines in overdose.

Authors:  N A Buckley; A H Dawson; I M Whyte; D L O'Connell
Journal:  BMJ       Date:  1995-01-28
View more
  5 in total

1.  The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach.

Authors:  Lena E Friberg; Geoffrey K Isbister; L Peter Hackett; Stephen B Duffull
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

2.  The feasibility of administration of activated charcoal with respect to current practice guidelines in emergency department patients.

Authors:  Frank LoVecchio; J Shriki; K Innes; J Bermudez
Journal:  J Med Toxicol       Date:  2007-09

Review 3.  Who gets antidotes? choosing the chosen few.

Authors:  Nicholas A Buckley; Andrew H Dawson; David N Juurlink; Geoffrey K Isbister
Journal:  Br J Clin Pharmacol       Date:  2016-02-17       Impact factor: 4.335

4.  Gastrointestinal decontamination in the acutely poisoned patient.

Authors:  Timothy E Albertson; Kelly P Owen; Mark E Sutter; Andrew L Chan
Journal:  Int J Emerg Med       Date:  2011-10-12

5.  Intensity of care delivered by prehospital emergency medical service physicians to patients with deliberate self-poisoning: results from a 2-day cross-sectional study in France.

Authors:  Maxime Maignan; Damien Viglino; Roselyne Collomb Muret; Nathan Vejux; Eric Wiel; Laurent Jacquin; Said Laribi; Papa N-Gueye; Luc-Marie Joly; Florence Dumas; Sebastien Beaune
Journal:  Intern Emerg Med       Date:  2019-05-18       Impact factor: 3.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.